News & Analysis as of

Big Tech Food and Drug Administration (FDA)

Wiley Rein LLP

Wiley Consumer Protection Download (September 11, 2023)

Wiley Rein LLP on

Welcome to Wiley’s update on recent developments and what’s next in consumer protection at the Consumer Financial Protection Bureau (CFPB) and Federal Trade Commission (FTC). In this newsletter, we analyze recent regulatory...more

Robins Kaplan LLP

China Unexpectedly Cuts Key Benchmark Rate in Attempt to Jump-Start Flagging Economy

Robins Kaplan LLP on

Chinese central bankers unexpectedly cut a benchmark interest rate today, an “unexpected policy shift” in an era of rate hikes that “economists said would likely help the country’s moribund housing market but bring only...more

Robins Kaplan LLP

Financial Daily Dose 8.24.2021 | Top Story: Full FDA Pfizer Vax Approval Buoys Markets

Robins Kaplan LLP on

Markets used news of the FDA’s full approval of the Pfizer BioNTech coronavirus vaccine as the excuse they needed to jump back up after a few days of losses. All three major indices were up near the 1% range, with the Nasdaq...more

Spilman Thomas & Battle, PLLC

Decoded: Technology Law Insights, Volume 2, Issue 15

Bye-Bye, Bitcoin: It's Time to Ban Cryptocurrencies - "International banking officials say cryptocurrencies such as bitcoin are speculative assets, not sustainable, usable money." Why this is important: This opinion piece...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide